Metipranolol Ophthalmic and Moxetumomab Pasudotox-tdfk
Determining the interaction of Metipranolol Ophthalmic and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: metipranolol ophthalmic
Brand name:
Synonyms: Metipranolol
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Metipranolol Ophthalmic-Moxetumomab pasudotox-tdfk Intravenous
- Metipranolol Ophthalmic-Moxifloxacin
- Metipranolol Ophthalmic-Moxifloxacin (Systemic)
- Metipranolol Ophthalmic-Moxifloxacin Hydrochloride
- Metipranolol Ophthalmic-Moxifloxacin Injection
- Metipranolol Ophthalmic-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Metoclopramide
- Moxetumomab Pasudotox-tdfk-Metoclopramide Hydrochloride
- Moxetumomab Pasudotox-tdfk-Metoclopramide Injection
- Moxetumomab Pasudotox-tdfk-Metoclopramide Injection Solution
- Moxetumomab Pasudotox-tdfk-Metoclopramide Intravenous
- Moxetumomab Pasudotox-tdfk-Metoclopramide Oral Solution